Loss of Diphthamide Increases DNA Replication Stress in Mammalian Cells by Modulating the Translation of RRM1
Diphthamide (DPH) is a highly conserved post-translational modification exclusively present in eukaryotic translation elongation factor 2 (eEF2), with its loss leading to embryonic lethality in mice and developmental disorders in humans. In this study, we unveil the role of diphthamide in mammalian cell DNA damage stress, with a particular emphasis on DNA replication stress. We developed a systematic strategy to identify human proteins affected by diphthamide with a combination of computational profiling and quantitative proteomics. Through this approach, we determine that the translation of RRM1 is modulated by diphthamide via -1 frameshifting. Importantly, our results reveal that the dysregulation of RRM1 translation in DPH-deficient cells is causally linked to elevated DNA replication stress. These findings provide a potential explanation for how diphthamide deficiency leads to cancer and developmental defects in humans.
Authors
- Hening Lin (ORCID: https://orcid.org/0000-0002-0255-2701)
- Byunghyun Ahn (ORCID: https://orcid.org/0000-0003-1593-1660)
- Jiaqi Zhao (ORCID: https://orcid.org/0009-0004-6264-9072)
Institutions
- Howard Hughes Medical Institute (US)
- Cornell University (US)
Publication Details
- Journal
- ACS Central Science
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1021/acscentsci.4c00967
- Citations
- 14
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 3.27
Funders
- Howard Hughes Medical Institute
- National Institutes of Health